Chief Scientific Officer Neil Cashman buys 15,000 shares of PMN at $0.97; holdings rise to 16,617 shares (+927.6%)
Cashman purchased 15,000 shares at $0.97 on 2025-02-10, increasing his position from 1,617 to 16,617 shares—a 927.6% increase in holdings. The current price is $22.80, reflecting a significant rallying market price relative to his transaction price, though the stock remains -63.4% below its 52-week high of $62.25. The company reports net income of $9,275,825.00, yet also carries negative full-year net income from the most recent fiscal year, indicating inconsistency between the current and historical profitability picture. The substantial expansion of the CSO's equity stake during a period of stock weakness (down 8.8% in 30 days) warrants examination of whether this reflects his conviction in near-term strategy, though the transaction details alone do not resolve whether the company's recent return to profitability signals durable recovery or temporary improvement.